Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [119]
elearning [13]
Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL
Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA
Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )
17 Dec 2018
Phase II trial of nivolumab combined with ibrutinib for patients with Richter...
Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA
Phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )
17 Dec 2018
Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia
Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona...
Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia ( Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain )
17 Dec 2018
Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed...
Dr Habte Yimer - Texas Oncology, Tyler, USA
Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed multiple myeloma ( Dr Habte Yimer - Texas Oncology, Tyler, USA )
17 Dec 2018
Blinatumomab as second salvage therapy in adults with relapsed/refractory...
Prof Alessandro Rambaldi - University of Milan, Milan, Italy
Blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-NHL ( Prof Alessandro Rambaldi - University of Milan, Milan, Italy )
13 Dec 2018
Efficacy and safety of KRd or KCd induction in multiple myeloma
Dr Francesca Gay - University of Torino, Torino, Italy
Efficacy and safety of KRd or KCd induction in multiple myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )
13 Dec 2018
Maintenance therapy with the oral PI ixazomib significantly prolongs PFS...
Dr Francesca Gay - University of Torino, Torino, Italy
Maintenance therapy with the oral PI ixazomib significantly prolongs PFS following ASCT in multiple myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )
13 Dec 2018
Results from the EMN-011 trial, combination therapy for multiple myeloma
Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands
Results from the EMN-011 trial, combination therapy for multiple myeloma ( Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands )
13 Dec 2018
Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative...
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
Cytotoxic T lymphocyte cell therapy for post-transplant lymphoproliferative disorder in the central nervous system ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )
13 Dec 2018
Clinical impact of an accurate genetic characterisation of older AML patients
Prof Alessandro Rambaldi - University of Milan, Milan, Italy
Clinical impact of an accurate genetic characterisation of older AML patients ( Prof Alessandro Rambaldi - University of Milan, Milan, Italy )
13 Dec 2018
Two clinical trials using combination therapy in adult patients with multiple...
Dr Irene M. Ghobrial - Dana-Farber Cancer Institute, Boston, USA
Two clinical trials using combination therapy in adult patients with multiple myeloma ( Dr Irene M. Ghobrial - Dana-Farber Cancer Institute, Boston, USA )
12 Dec 2018
The combined analysis of carfilzomib trials for multiple myeloma
Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain
The combined analysis of carfilzomib trials for multiple myeloma ( Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain )
7 Dec 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation